Health Bulletin 21/October/2023 Roshni Dhar21 Oct 2023 5:20 PM ISTHere are the top health stories for the day:145 doctors convicted under PCPNDT act suspended by state medical councils: Union Health Minister...
First dengue pill shows promise in human challenge trial Ruchika Sharma21 Oct 2023 4:58 PM ISTNew Delhi: A pill for dengue fever developed by Johnson & Johnson appeared to protect against a form of the virus in a handful of patients in a...
JnJ embarks on two year restructuring program for orthopedics business Ruchika Sharma19 Oct 2023 12:25 PM ISTNew Jersy: Johnson & Johnson has said it has embarked on a two-year restructuring program for its orthopedics business after third-quarter...
Sanofi, Janssen ink pact to develop vaccine for extraintestinal pathogenic E. coli Ruchika Sharma4 Oct 2023 5:30 PM ISTSanofi will pay USD 175M upfront to Janssen, followed by development and commercial milestones.
Phase 3 Mariposa study evaluating Rybrevant plus Lazertinib meets primary endpoint in PFS in Non-Small Cell Lung Cancer: Janssen Ruchika Sharma2 Oct 2023 10:00 AM ISTRartan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced positive topline results from the Phase 3 MARIPOSA study...
Johnson & Johnson Vision launches SILK procedure performed with next generation laser vision correction solution in India Ruchika Sharma23 Sept 2023 11:28 AM ISTThe procedure is easy, performed using the next-generation laser vision correction solution that gently creates a small disk-shaped lens, called a...
JnJ, P&G, Walgreens accused in lawsuits over cold medicine decongestant Ruchika Sharma15 Sept 2023 2:30 PM ISTJohnson & Johnson, Procter & Gamble and Walgreens are among several companies accused in lawsuits of deceiving consumers about cold...
Janssen declares positive topline results from Phase 3 study evaluating RYBREVANT given with, without lazertinib combined with chemotherapy versus chemotherapy alone Ruchika Sharma9 Sept 2023 1:45 PM ISTNew Jersey: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced positive topline results from the three-arm Phase 3 ...
Johnson & Johnson to halt hypertension drug Macitentan study Ruchika Sharma8 Sept 2023 11:43 AM ISTThe study was deemed "futile" and failed to improve exercise capacity in a broad population including inoperable patients compared to a placebo, J&J...
Novartis sues US government over Medicare drug price regulation Ruchika Sharma4 Sept 2023 11:31 AM ISTThe pharmaceutical industry says the program will curtail profits and compel it to pull back on developing new treatments.
Conduct Phase-III clinical trial in India: CDSCO panel tells Johnson and Johnson Over Guselkumab Dr. Divya Colin2 Sept 2023 6:00 PM ISTNew Delhi: Citing that there is no clinical data available on the Indian Population, the Subject Expert Committee (SEC) functional under the Central...
Janssen seeks USFDA full approval for Balversa for Urothelial Carcinoma Ruchika Sharma1 Sept 2023 12:30 PM ISTRaritan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a supplemental New Drug Application...
